p493F12 kinase: a novel MAP kinase expressed in a subset of neurons in the human nervous system.Mohit A.A., Martin J.H., Miller C.A.View abstractCited forNUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-1)TissueHippocampusCategoriesSequencesSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCNeuron 14:67-78 (1995)Cited in1
Selective interaction of JNK protein kinase isoforms with transcription factors.Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., Davis R.J.View abstractCited forNUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA-1 AND ALPHA-2)TissueBrainCategoriesSequencesSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCEMBO J. 15:2760-2770 (1996)Cited in3
Complete sequencing and characterization of 21,243 full-length human cDNAs.Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H.[...], Sugano S.View abstractCited forNUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 143-464 (ISOFORM ALPHA-1)TissueCaudate nucleusCategoriesSequencesSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCNat. Genet. 36:40-45 (2004)Cited in99+99+
Generation and annotation of the DNA sequences of human chromosomes 2 and 4.Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K.[...], Wilson R.K.View abstractCited forNUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]CategoriesSequencesSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCNature 434:724-731 (2005)Cited in99+99+
No title available.Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H.[...], Venter J.C.Cited forNUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]CategoriesSequencesSourceUniProtKB reviewed (Swiss-Prot)Submission Submitted to EMBL/GenBank/DDBJ databases (JUL-2005)Cited in99+
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).The MGC Project TeamView abstractCited forNUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-2)TissueBrainCategoriesSequencesSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCGenome Res. 14:2121-2127 (2004)Cited in99+99+
Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1.Lisnock J., Griffin P., Calaycay J., Frantz B., Parsons J., O'Keefe S.J., LoGrasso P.View abstractCited forPARTIAL PROTEIN SEQUENCE, REGULATION BY MAP2K4 AND MAP2K7, PHOSPHORYLATION AT THR-221 AND TYR-223, COFACTOR, MASS SPECTROMETRYCategoriesFunction, PTM / Processing, SequencesSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCBiochemistry 39:3141-3148 (2000)Cited in1
Synergistic activation of stress-activated protein kinase 1/c-Jun N- terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.Fleming Y., Armstrong C.G., Morrice N., Paterson A., Goedert M., Cohen P.View abstractCited forACTIVITY REGULATIONCategoriesFunctionSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCBiochem. J. 352:145-154 (2000)Cited in3
c-Jun N-terminal kinase-3 (JNK3)/stress-activated protein kinase-beta (SAPKbeta) binds and phosphorylates the neuronal microtubule regulator SCG10.Neidhart S., Antonsson B., Gillieron C., Vilbois F., Grenningloh G., Arkinstall S.View abstractCited forFUNCTION IN PHOSPHORYLATION OF STMN2CategoriesFunction, PTM / ProcessingSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCFEBS Lett. 508:259-264 (2001)Cited in1Mapped to1
Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein.Jagadish N., Rana R., Selvi R., Mishra D., Garg M., Yadav S., Herr J.C., Okumura K., Hasegawa A.[...], Suri A.View abstractCited forINTERACTION WITH SPAG9CategoriesInteractionSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCBiochem. J. 389:73-82 (2005)Cited in4
Truncation of the CNS-expressed JNK3 in a patient with a severe developmental epileptic encephalopathy.Shoichet S.A., Duprez L., Hagens O., Waetzig V., Menzel C., Herdegen T., Schweiger S., Dan B., Vamos E.[...], Kalscheuer V.M.View abstractCited forCHROMOSOMAL REARRANGEMENT, DISEASECategoriesSequences, Disease & VariantsSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCHum. Genet. 118:559-567 (2006)Cited in1
Visual and both non-visual arrestins in their 'inactive' conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm.Song X., Raman D., Gurevich E.V., Vishnivetskiy S.A., Gurevich V.V.View abstractCited forSUBCELLULAR LOCATIONCategoriesSubcellular LocationSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCJ. Biol. Chem. 281:21491-21499 (2006)Cited in1Mapped to15
Neuroprotection by histone deacetylase-related protein.Morrison B.E., Majdzadeh N., Zhang X., Lyles A., Bassel-Duby R., Olson E.N., D'Mello S.R.View abstractCited forINTERACTION WITH HDAC9, ACTIVITY REGULATIONCategoriesFunction, InteractionSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCMol. Cell. Biol. 26:3550-3564 (2006)Cited in5
Mutations of beta-arrestin 2 that limit self-association also interfere with interactions with the beta2-adrenoceptor and the ERK1/2 MAPKs: implications for beta2-adrenoceptor signalling via the ERK1/2 MAPKs.Xu T.-R., Baillie G.S., Bhari N., Houslay T.M., Pitt A.M., Adams D.R., Kolch W., Houslay M.D., Milligan G.View abstractCited forINTERACTION WITH ARRB2CategoriesInteractionSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCBiochem. J. 413:51-60 (2008)Cited in4Mapped to6
Isoform-specific palmitoylation of JNK regulates axonal development.Yang G., Liu Y., Yang K., Liu R., Zhu S., Coquinco A., Wen W., Kojic L., Jia W., Cynader M.View abstractCited forPALMITOYLATION AT CYS-462 AND CYS-463, MUTAGENESIS OF CYS-462 AND CYS-463CategoriesPTM / Processing, Disease & VariantsSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCCell Death Differ. 19:553-561 (2012)Cited in1
JNK regulates the photic response of the mammalian circadian clock.Yoshitane H., Honma S., Imamura K., Nakajima H., Nishide S.Y., Ono D., Kiyota H., Shinozaki N., Matsuki H.[...], Fukada Y.View abstractCited forFUNCTIONCategoriesFunctionSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCEMBO Rep. 13:455-461 (2012)Cited in6Mapped to33
The same pocket in menin binds both MLL and JUND but has opposite effects on transcription.Huang J., Gurung B., Wan B., Matkar S., Veniaminova N.A., Wan K., Merchant J.L., Hua X., Lei M.View abstractCited forFUNCTION, INTERACTION WITH JUNDCategoriesFunction, InteractionSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCNature 482:542-546 (2012)Cited in7Mapped to19
Crystal structure of JNK3: a kinase implicated in neuronal apoptosis.Xie X., Gu Y., Fox T., Coll J.T., Fleming M.A., Markland W., Caron P.R., Wilson K.P., Su M.S.-S.View abstractCited forX-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 40-402CategoriesStructureSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCStructure 6:983-991 (1998)Cited in1
A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion.Mizukami Y., Yoshioka K., Morimoto S., Yoshida K.i.View abstractAnnotationPathwayCategoriesFunctionSourceReactome: R-HSA-450214, Reactome: R-HSA-450311PubMedEurope PMCJ Biol Chem 272:16657-16662 (1997)Mapped to7
Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo.Deacon K., Blank J.L.View abstractAnnotationPathwayCategoriesFunctionSourceReactome: R-HSA-450214, Reactome: R-HSA-450352PubMedEurope PMCJ Biol Chem 272:14489-14496 (1997)Mapped to6
Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells.Mersal K.I., Abdel-Maksoud M.S., Ali E.M.H., Ammar U.M., Zaraei S.O., Haque M.M., Das T., Hassan N.F., Kim E.E.[...], Oh C.H.View abstractCategoriesStructureSourcePDB: 8ENJPubMedEurope PMCEur J Med Chem 261:115779-115779 (2023)Mapped to1
Principles and Applications of CF<sub>2</sub>X Moieties as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical Biology, and Drug Discovery.Vaas S., Zimmermann M.O., Schollmeyer D., Stahlecker J., Engelhardt M.U., Rheinganz J., Drotleff B., Olfert M., Lammerhofer M.[...], Boeckler F.M.View abstractCategoriesStructureSourcePDB: 8BZPPubMedEurope PMCJ Med Chem 66:10202-10225 (2023)Mapped to1
<i>N</i>-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors.Feng Y., Park H., Ryu J.C., Yoon S.O.View abstractCategoriesStructureSourcePDB: 7S1NPubMedEurope PMCACS Med Chem Lett 12:1546-1552 (2021)Mapped to1
Controlling the Covalent Reactivity of a Kinase Inhibitor with Light.Reynders M., Chaikuad A., Berger B.T., Bauer K., Koch P., Laufer S., Knapp S., Trauner D.View abstractCategoriesStructureSourcePDB: 7ORE, PDB: 7ORFPubMedEurope PMCAngew Chem Int Ed Engl 60:20178-20183 (2021)Mapped to1
Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors.Feng Y., Park H., Bauer L., Ryu J.C., Yoon S.O.View abstractCategoriesStructureSourcePDB: 7KSI, PDB: 7KSJ, PDB: 7KSKPubMedEurope PMCACS Med Chem Lett 12:24-29 (2021)Mapped to1